[Cellular immunity and vaccination against cutaneous leishmaniasis. Recent progress and prospects].
Review of leishmaniasis immunopathogenesis, the models in the laboratory animals, and the last advances in the experimental vaccine administration. In recent years, there have been important progresses that have contributed substantially to classify the role of the interleukins and other chemical mediators in the immunologic response. All these advances open the door to the production of better and more immunogenic vaccines, that in a near future will be employed advantageous in the human beings.
Carrada Bravo
T
T
Hospital General de zona de Medicina Familiar número 2, IMSS Irapuato, Guanajuato.
D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000913:Antibodies, Protozoan / Q000096:biosynthesis / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007113:Immunity, Innate / Q000235:genetics / Q000276:immunology; D007153:Immunologic Deficiency Syndromes / Q000209:etiology; D007378:Interleukins / Q000502:physiology; D007893:Leishmania donovani / Q000276:immunology; D018320:Leishmania major / Q000235:genetics / Q000276:immunology; D016773:Leishmaniasis, Cutaneous / Q000276:immunology* / Q000517:prevention & control; D051379:Mice; D008815:Mice, Inbred Strains; D008819:Mice, Nude; D008969:Molecular Sequence Data; D009569:Nitric Oxide / Q000502:physiology; D016052:Protozoan Vaccines / Q000276:immunology*; D012486:Salmonella typhimurium / Q000235:genetics; D016176:T-Lymphocyte Subsets / Q000276:immunology; D014614:Vaccines, Synthetic
D000911:Antibodies, Monoclonal; D000913:Antibodies, Protozoan; D007378:Interleukins; D016052:Protozoan Vaccines; D014614:Vaccines, Synthetic; D009569:Nitric Oxide
La inmunidad celular y la vacunación contra la leishmaniasis cutánea. Progresos recientes y perspectivas.